| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2002024222A2 Ligands for g protein coupled receptors and methods of using them |
| 03/28/2002 | WO2002002595A9 Amphipathic linear peptides and compositions containing same |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | US20020037996 The peptides can impart photoreactivity to a protein by binding to a non-heme iron |
| 03/28/2002 | US20020037848 Alzheimer's disease; Parkinson's disease |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |
| 03/28/2002 | US20020037286 Methods for altering T cell and macrophage activation |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2421877A1 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | CA2420160A1 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/27/2002 | EP1190255A1 Epitopes formed by non-covalent association of conjugates |
| 03/27/2002 | EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 03/27/2002 | EP1189942A1 Somatostatin agonists |
| 03/27/2002 | EP1189941A1 Neuromedin b and somatostatin receptor agonists |
| 03/27/2002 | EP1189939A1 Bh3 modified peptides |
| 03/27/2002 | EP1189933A1 Echinocandin derivatives, method for preparing same and application as antifungal agents |
| 03/27/2002 | EP1189932A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | EP1189930A1 INHIBITORS OF THE INTEGRIN AlPHA V BETA 6 |
| 03/27/2002 | EP1189624A1 Hla binding peptides and their uses |
| 03/27/2002 | EP0733123B1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/27/2002 | CN1342167A Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362007 For diagnosis and therapy of systemic lupus erythematosus and related diseases, and diseases in which epstein-barr virus has been implicated |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022658A2 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 03/21/2002 | WO2002022657A2 Peptide antagonist of multiple chemokine receptors and uses thereof |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001079267A3 A glycopeptide and preparation thereof |
| 03/21/2002 | WO2001072958A3 Bladder cancer-specific peptides for diagnosis and therapy |
| 03/21/2002 | WO2001070672A3 Compounds and methods to treat alzheimer's disease |
| 03/21/2002 | WO2001068871A3 Human phospholipases and polynucleotides encoding the same |
| 03/21/2002 | WO2001064715A3 Memno peptides, a process for their preparation and their use |
| 03/21/2002 | WO2001058934A3 Kahalalide f and related compounds |
| 03/21/2002 | US20020035239 Active materials for grampositive bacteria, antibiotic resistance infections |
| 03/21/2002 | US20020035063 Derivatives of laspartomycin and preparation and use thereof |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020034766 Molecular modification assays |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2420504A1 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 03/20/2002 | EP1188768A2 LHRH antagonist peptides |
| 03/20/2002 | EP1187914A1 A structured peptide scaffold for displaying turn libraries on phages |
| 03/20/2002 | EP1187850A1 Antimicrobial theta defensins and methods of using same |
| 03/20/2002 | EP1187624A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | CN1341120A 骨刺激因子 Bone stimulator |
| 03/19/2002 | US6359113 Using fused ring system containing at least 4 aromatic rings, and group containing at least one carbon atom which is capable of bonding to a group to be protected; synthesis, separation |
| 03/19/2002 | US6359112 Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer's disease, in type II diabetes mellitus and in spongiform encephalophathies |
| 03/19/2002 | US6358927 Peptide fragments and analogs derived from PBAN 1-33 NH2 for controlling moths |
| 03/19/2002 | US6358921 Cyclic polypeptide with low hemolytic activity; killing fungi, mycoplama, grampositive and gramnegative bacteria; side effect reduction |
| 03/19/2002 | US6358511 Inhibitors of HIV infection |
| 03/19/2002 | US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors |
| 03/19/2002 | US6358489 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 03/19/2002 | US6358234 Absorbent article having deformed hinge and zones of extensibility |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2136330C Technetium-99m labeled peptides for thrombus imaging |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020618A1 Purification process |
| 03/14/2002 | WO2002020616A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | WO2002020610A2 Conformationally constrained labeled peptides for imaging and therapy |
| 03/14/2002 | WO2002020570A2 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening |
| 03/14/2002 | WO2002020561A1 Novel polypeptides and anti-hiv drugs containing the same |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020558A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 03/14/2002 | WO2002020557A1 Extended native chemical ligation |
| 03/14/2002 | WO2002020053A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/14/2002 | WO2002020035A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002019986A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | WO2001079268A3 A glycopeptide and preparation thereof |
| 03/14/2002 | WO2001070768A3 Receptor-binding compounds and method for identifying them |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032175 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 03/14/2002 | US20020031531 Immunotherapy for lung or urogenital cancer |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2422506A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421872A1 Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant |
| 03/14/2002 | CA2421448A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421445A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421183A1 Novel polypeptide and anti-hiv agent containing the same |
| 03/14/2002 | CA2420225A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | CA2419889A1 Purification process |
| 03/14/2002 | CA2412298A1 Extended native chemical ligation |
| 03/14/2002 | CA2389739A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |